SenoRx, Inc. Files For $86.25 Million IPO
WASHINGTON, May 25 (Reuters) - SenoRx Inc., which makes medical devices for diagnosing and treating breast cancer, on Thursday said it is planning an initial public offering for up to $86.25 million in common stock.